Innovations in Physiotherapy: Exploring New Technologies and Techniques That Improve Patient Outcomes
DUBAI, UAE / ACCESSWIRE / October 1, 2024 / Patient outcomes are being revolutionized by cutting-edge technologies and advanced physiotherapy...
Diagnostics
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of...
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR) Enables rapid, automated microbial identification on the Bruker...
HeartX Cardiovascular Accelerator Announces Four Startup Companies Selected for the 2024 Program
BENTONVILLE, Ark., Sept. 30, 2024 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices...
MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial
—First Multi-Center Randomized Controlled Clinical Trial in the US to Show MeMed BV's Impact on Reducing Unnecessary Antibiotics, Supporting Clinical...
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
Scalable and adaptable, TETRIS captures the diversity of protein interactions on site to inform accurate cancer diagnoses, enabling the personalisation...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...
Axtria Recognized for Excellence in AI with a Minsky Award at Cypher 2024
Axtria's GenAI innovations were recognized at India's most prestigious AI awards for driving operational excellence and transforming solutions for life...
Nexstim Receives Order for NBS System 5 in Finland
Press release, Helsinki, 27 September 2024 at 10 AM (EEST) Nexstim Receives Order for NBS System 5 in Finland Nexstim...
Defence’s Corporate Updates, Arranges Financing
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
EDETEK Presents New Approach to Real-Time Oversight of Clinical Trial Data Management
-- Presentation Demonstrates the CONFORM™ Bioinformatics Digital Platform -- PRINCETON, N.J., Sept. 26, 2024 /PRNewswire/ -- EDETEK Inc., a leading...
Babson Diagnostics Partners with Orchard Software to Provide Innovative BetterWay Blood Testing Service
CARMEL, Ind., Sept. 26, 2024 /PRNewswire/ -- Today, Orchard Software highlights its partnership with Babson Diagnostics in Austin, Texas. Babson Diagnostics...
Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis
SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial...
Koan Health Convenes ACO Leaders at Annual Executive Forum
Industry experts gather to discuss strategies and share insights for advancing value-based care success. DALLAS, Sept. 26, 2024 /PRNewswire/ --...
Global Health Exhibition to Showcase Unique Advances in AI-Enabled Diagnostics and Patient Care
The event's Digital Health Forum will reveal the world's latest developments in artificial intelligence (AI) enabled diagnostic decision-making for an...
LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore,...
New Data Reveals BD’s Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
FRANKLIN LAKES, N.J., Sept. 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,...
Angle PLC Announces Half-year Report
Interim Results for the six months ended 30 June 2024LARGE PHARMA STRATEGY IMPLEMENTED SUCCESSFULLYThree Large Pharma contracts secured each with...
RIVANNA secures patent for groundbreaking ultrasound-guided needle insertion system
CHARLOTTESVILLE, Va., Sept. 25, 2024 /PRNewswire/ -- RIVANNA®, developers of world-first imaging-based medical solutions, announced the acquisition of a groundbreaking...